Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Hedgehog signaling in cancer and therapeutic potential (CROSBI ID 606904)

Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija

Levanat, Sonja ; Car, Diana ; Sabol, Maja ; Musani, Vesna ; Ozretic, Petar, Gojevic, Ante ; Oreskovic, Slavko Hedgehog signaling in cancer and therapeutic potential // Kancerološka sekcija SLD i sekcija sestara u onkologiji UMSTBS / Srpsko lekarsko društvo Kancerološka sekcija (ur.). Beograd: Kancerološka sekcija SLD, 2012. str. 25-25

Podaci o odgovornosti

Levanat, Sonja ; Car, Diana ; Sabol, Maja ; Musani, Vesna ; Ozretic, Petar, Gojevic, Ante ; Oreskovic, Slavko

engleski

Hedgehog signaling in cancer and therapeutic potential

The Hedgehog-Gli (Hh-Gli) signaling pathway is a developmental pathway, which is often found aberrantly active in various tumors. The pathway is a highly coordinated and orchestrated network involving binding of the ligand Hedgehog (Hh) to its receptor, a twelve transmembrane protein, Patched (Ptch). This causes Ptch to release its repression over the coreceptor Smoothened (Smo), a seven transmembrane protein and triggers a cascade of events in the cytoplasm leading to activation of the transcription factor Gli and transcription of target genes. The Gli proteins are regulated by the Suppressor of Fused (SuFu), Protein Kinase A (PKA), Glycogen Synthase Kinase 3β (GSK3β) and Casein Kinase 1 (CK1). The involvement of the Hh-Gli signaling pathway in a variety of human cancers based on preclinical in vitro and in vivo data demonstrate a role of this pathway in cancer pathogenesis, self-renewal and chemotherapy resistance. Our recent results on colon cancer and ovarian carcinoma will be presented as examples of the involvment of the Hh-Gli signaling pathway in the pathogenesis of different tumors, and will show different levels of pathway alterations. To date several Smo inhibitors have been proposed as potential candidates for cancer therapy either as a single agent or in combination regimens with conventional chemotherapy. There is a need for better understanding of the modes of Hh-Gli pathway regulation in different tumors, its role in tumor response to traditional therapy, as well as the interactions of the Hh-Gli pathway with other signaling pathways in order to develop better therapies based on combinations with inhibitors of the Hh-Gli signaling pathway

Hedgehog signaling; cancer; therapy

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

25-25.

2012.

objavljeno

Podaci o matičnoj publikaciji

Kancerološka sekcija SLD i sekcija sestara u onkologiji UMSTBS

Srpsko lekarsko društvo Kancerološka sekcija

Beograd: Kancerološka sekcija SLD

978-86-6061-049-4

Podaci o skupu

Kancerološka nedelja

pozvano predavanje

30.11.2012-30.11.2012

Beograd, Srbija

Povezanost rada

Temeljne medicinske znanosti